Qianqian Zheng

China Medical University
Shenyang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Decoding the CHI3L1/IL-13Rα2 signaling nexus in MASH-fibrosis pathogenesis.

Decoding the CHI3L1/IL-13Rα2 signaling nexus in MASH-fibrosis pathogenesis.

Journal: Science advances

Published: December 10, 2025

6PPD impairs liver growth through inflammatory pathways: Insights from zebrafish and human cell models.

6PPD impairs liver growth through inflammatory pathways: Insights from zebrafish and human cell models.

Journal: Comparative biochemistry and physiology. Toxicology & pharmacology : CBP

Published: October 22, 2025

Fungal commensal promotes intestinal repair via its secreted peptide in mice.

Fungal commensal promotes intestinal repair via its secreted peptide in mice.

Journal: Nature microbiology

Published: May 20, 2025

Killing hepatocellular carcinoma in the NAFLD/NASH stage: a comprehensive perspective on targeting regulated cell death.

Killing hepatocellular carcinoma in the NAFLD/NASH stage: a comprehensive perspective on targeting regulated cell death.

Journal: Cell death discovery

Published: February 11, 2025

Gut microbiota and urological cancers: from microecological imbalance to potential for precision therapy.

Gut microbiota and urological cancers: from microecological imbalance to potential for precision therapy.

Journal: Discover oncology

Published: December 19, 2024

Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice.

Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice.

Journal: Science advances

Published: October 23, 2024

HNF4α-CDKL3 axis restricts MASLD progression by targeting FoxO1 via noncanonical phosphorylation.

HNF4α-CDKL3 axis restricts MASLD progression by targeting FoxO1 via noncanonical phosphorylation.

Journal: Hepatology (Baltimore, Md.)

Published: April 15, 2024

Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4.

Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: April 04, 2024

Gut microbiome-metabolites axis: A friend or foe to colorectal cancer progression.

Gut microbiome-metabolites axis: A friend or foe to colorectal cancer progression.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 09, 2024

Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression.

Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression.

Journal: Molecular carcinogenesis

Published: October 13, 2023

Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis.

Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 14, 2023

PHF23 promotes NSCLC proliferation, metastasis, and chemoresistance via stabilization of ACTN4 and activation of the ERK pathway.

PHF23 promotes NSCLC proliferation, metastasis, and chemoresistance via stabilization of ACTN4 and activation of the ERK pathway.

Journal: Cell death & disease

Published: April 17, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026